These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 18418410

  • 1. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y, Yoshida S, Saito Y, Doi T, Nagatoshi Y, Fukata M, Saito N, Yang SM, Iwamoto C, Okamura J, Liu KY, Huang XJ, Lu DP, Shultz LD, Harada M, Ishikawa F.
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [Abstract] [Full Text] [Related]

  • 2. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G, Baumann M, Meltzer J, Möllers T, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1996 Jun; 208(4):160-7. PubMed ID: 8926682
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1997 Jun; 209(4):178-85. PubMed ID: 9293448
    [Abstract] [Full Text] [Related]

  • 6. Expression of integrin α2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2Rγ(c) null mice.
    Wong WM, Sigvardsson M, Åstrand-Grundström I, Hogge D, Larsson J, Qian H, Ekblom M.
    Stem Cells; 2013 Feb; 31(2):360-71. PubMed ID: 23165626
    [Abstract] [Full Text] [Related]

  • 7. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
    Lapidot T, Grunberger T, Vormoor J, Estrov Z, Kollet O, Bunin N, Zaizov R, Williams DE, Freedman MH.
    Blood; 1996 Oct 01; 88(7):2655-64. PubMed ID: 8839860
    [Abstract] [Full Text] [Related]

  • 8. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
    van Rhenen A, Moshaver B, Kelder A, Feller N, Nieuwint AW, Zweegman S, Ossenkoppele GJ, Schuurhuis GJ.
    Leukemia; 2007 Aug 01; 21(8):1700-7. PubMed ID: 17525725
    [Abstract] [Full Text] [Related]

  • 9. Production of human B cells from CD34+CD38- T- B- progenitors in organ culture by sequential cytokine stimulation.
    DeLuca D, Basye JL, Schumacher MJ, Lebsack TW.
    Dev Comp Immunol; 2006 Aug 01; 30(11):1084-98. PubMed ID: 16581123
    [Abstract] [Full Text] [Related]

  • 10. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
    Ueda T, Yoshino H, Kobayashi K, Kawahata M, Ebihara Y, Ito M, Asano S, Nakahata T, Tsuji K.
    Stem Cells; 2000 Aug 01; 18(3):204-13. PubMed ID: 10840074
    [Abstract] [Full Text] [Related]

  • 11. [Proportions of cells expressing CD38-/CD34+, CD38+/CD34+, CD19+/CD34+, or CD13,33+/CD34+ in the regenerating bone marrows during complete remission of acute leukemia or after bone marrow transplantation].
    Kahng J, Shin SY, Han K.
    Korean J Lab Med; 2007 Dec 01; 27(6):406-13. PubMed ID: 18160830
    [Abstract] [Full Text] [Related]

  • 12. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.
    Lamkin T, Brooks J, Annett G, Roberts W, Weinberg K.
    Leukemia; 1994 Nov 01; 8(11):1871-8. PubMed ID: 7526089
    [Abstract] [Full Text] [Related]

  • 13. [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].
    Kong Y, Liu YR, Liu KY, Huang XJ, Ishikawa F, Harada M.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun 01; 20(3):762-8. PubMed ID: 22739198
    [Abstract] [Full Text] [Related]

  • 14. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
    Eisterer W, Jiang X, Christ O, Glimm H, Lee KH, Pang E, Lambie K, Shaw G, Holyoake TL, Petzer AL, Auewarakul C, Barnett MJ, Eaves CJ, Eaves AC.
    Leukemia; 2005 Mar 01; 19(3):435-41. PubMed ID: 15674418
    [Abstract] [Full Text] [Related]

  • 15. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.
    Aoki Y, Watanabe T, Saito Y, Kuroki Y, Hijikata A, Takagi M, Tomizawa D, Eguchi M, Eguchi-Ishimae M, Kaneko A, Ono R, Sato K, Suzuki N, Fujiki S, Koh K, Ishii E, Shultz LD, Ohara O, Mizutani S, Ishikawa F.
    Blood; 2015 Feb 05; 125(6):967-80. PubMed ID: 25538041
    [Abstract] [Full Text] [Related]

  • 16. Human cord blood long-term engrafting cells are CD34+ CD38-.
    Ishikawa F, Livingston AG, Minamiguchi H, Wingard JR, Ogawa M.
    Leukemia; 2003 May 05; 17(5):960-4. PubMed ID: 12750710
    [Abstract] [Full Text] [Related]

  • 17. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D, Bhatia M, Wang JC, Kapp U, Dick JE.
    Bone Marrow Transplant; 1999 Feb 05; 23(3):203-9. PubMed ID: 10084250
    [Abstract] [Full Text] [Related]

  • 18. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
    Nishioka C, Ikezoe T, Furihata M, Yang J, Serada S, Naka T, Nobumoto A, Kataoka S, Tsuda M, Udaka K, Yokoyama A.
    Int J Cancer; 2013 May 01; 132(9):2006-19. PubMed ID: 23055153
    [Abstract] [Full Text] [Related]

  • 19. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J, Orfao A, Vidriales B, Macedo A, Martínez A, González M, López-Berges MC, Valverde B, San Miguel JF.
    Haematologica; 1998 Dec 01; 83(12):1069-75. PubMed ID: 9949623
    [Abstract] [Full Text] [Related]

  • 20. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM, Belch AR.
    Clin Cancer Res; 2002 Oct 01; 8(10):3198-204. PubMed ID: 12374689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.